Table 1 Patient characteristics (numbers of patients unless stated otherwise)
From: MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
Early-stage (FIGO IA-Ic) (n = 23) | Advanced-stage FIGO (IIB-IV) (n = 74) | Total (n = 97) | |
|---|---|---|---|
Age (median (min-max)) | 59 (24–81) | 64 (30–84) | 62 (24–84) |
Histological subtype | |||
Low-grade serous | 10 | 14 | 24 |
High-grade serous | 0 | 42 | 42 |
Mucinous | 4 | 4 | 8 |
Endometroid | 1 | 3 | 4 |
Clear cell | 6 | 2 | 8 |
Adenocarcinoma unspecified | 7 | 7 | |
Mixed | 2 | 2 | 4 |
Differentiation | |||
Low-grade | 12 | 18 | 30 |
High-grade | 11 | 56 | 67 |
CA 125 (median (min-max)) | 61 (7–3222) | 615 (9–37500) | 332 (7–37500) |
FIGO stage | |||
IA-IC | 23 | 23 | |
IIB | 14 | 14 | |
III | 44 | 44 | |
IV | 16 | 16 | |
Debulking (only advanced stage disease) | |||
Complete | 62 | ||
Incomplete | 12 | ||
Overall Survival (months (minimum-maximum)) | 64 (28–75) | 38 (0–76) | 50 (0–76) |
Number of deceased patients | 4 | 51 | 55 |